Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Oct;84(10):1078-85.
doi: 10.1111/j.1349-7006.1993.tb02804.x.

Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice

M Takenaga  1 , R Igarashi, H Tsuji, Y Mizushima
Affiliations
Comparative Study

Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice

M Takenaga et al. Jpn J Cancer Res. 1993 Oct.

Abstract

Stable lipid microspheres (LM) and lipid nanospheres (LN) with average diameters of 200 nm and 50 nm, respectively, were used to encapsulate an lipophilic antitumor agent, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). LM and LN containing BCNU (lipo BCNU and s-lipo BCNU, respectively) were prepared by homogenizing a soybean oil solution of BCNU with egg yolk lecithin, and their antitumor activity via the intravenous route was tested against L1210 leukemia in mice and compared with that of BCNU dissolved in saline. Both lipo-BCNU and s-lipo BCNU showed significantly enhanced antitumor activity with reduced toxicity, when compared with the corresponding doses of BCNU alone. These results suggest that LM and LN may be suitable carriers for lipophilic antitumor agents and may enhance their efficacy.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Papahadjopoulos , D.Liposomes and their uses in biology and medicine . Ann. N.Y. Acad. Sci. , 308 , 1 – 462 ( 1978. ). - PubMed
    1. Kato , T.Encapsulated drugs in targeted cancer therapy . In “ Controlled Drug Delivery ,” ed. Bruck S. R. , pp . 189 – 195 ( 1983. ). CRC Press; , Boca Raton .
    1. Konno , H. , Suzuki , H. , Tadakuma , T. , Kumai , K. , Yasuda , T. , Kubota , T. , Ohta , S. , Nagaike , K. , Hosokawa , S. , Ishibiki , K. , Abe , O. and Saito , K.Antitumor effect of adriamycin‐entrapped liposomes conjugated with antihuman α‐fetoprotein monoclonal antibody . Cancer Res. , 47 , 4471 – 4477 ( 1987. ). - PubMed
    1. Matthay , K. K. , Abai , A. M. , Cobb , S. , Hong , K. , Papahadjopoulos , D. and Straubinger , R. M.Role of ligand antibody‐directed endocytosis of liposomes by human T‐leukemia cells . Cancer Res. , 49 , 4879 – 4886 ( 1989. ). - PubMed
    1. Loeffler , C. M. , Platt , J. L. , Manderson , P. , Katsanis , E. , Ochoa , J. B. , Urba , W. J. , Longo , D. L. , Leonard , A. S. and Ochoa , A. C.Antitumor effect of interleukin‐2 liposomes and anti‐CD3‐stimulated T cells against murine MCA‐38 hepatic metastasis . Cancer Res. , 51 , 2127 – 2132 ( 1991. ). - PubMed

Publication types

LinkOut - more resources